Laurus Labs has reported a robust financial performance for Q2 2026, with revenue from operations reaching ₹1,653.47 crore. The Board has approved an interim dividend of ₹0.80 per share. Net profit after tax stood at ₹193.75 crore. The company has fixed October 31, 2025, as the record date for determining shareholders’ eligibility for the dividend, which will be paid on or after November 12, 2025.
Financial Performance in Q2 2026
Laurus Labs announced strong consolidated unaudited financial results for the quarter ended September 30, 2025. Key highlights include:
- Revenue from operations: ₹1,653.47 crore compared to ₹1,223.70 crore in Q2 2025.
- Other income: ₹26.96 crore.
- Total Income: ₹1,680.43 crore.
- Profit before tax: ₹269.73 crore.
- Net Profit after tax: ₹193.75 crore.
Interim Dividend Announcement
The Board of Directors has approved the payment of an interim dividend of ₹0.80 (40%) per equity share of ₹2 each for the financial year 2025-26.
The “Record Date” for determining the eligibility of shareholders for the dividend is October 31, 2025. The dividend amount will be paid on or after November 12, 2025.
Segmental Performance
The company operates in the pharmaceuticals sector.
Balance Sheet Highlights (Consolidated)
- Total Equity: ₹4,933.53 Crores
- Total Assets: ₹9,415.25 Crores
Standalone Financial Performance
- Revenue from operations: ₹1,566.60 crore
- Net Profit after tax: ₹215.67 crore
Source: BSE
